44 related articles for article (PubMed ID: 17048471)
1. Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes.
Zagana P; Mourtas S; Basta A; Antimisiaris SG
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32268585
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Characterization of Arsenolipids: Naturally Occurring Arsenic Compounds in Fish and Algae.
Taleshi MS; Seidler-Egdal RK; Jensen KB; Schwerdtle T; Francesconi KA
Organometallics; 2014 Mar; 33(6):1397-1403. PubMed ID: 24683287
[TBL] [Abstract][Full Text] [Related]
3. Erratum to "Integrating Therapeutic Ultrasound With Nanosized Drug Delivery Systems in the Battle Against Cancer".
Technol Cancer Res Treat; 2024; 23():15330338231223384. PubMed ID: 38343160
[No Abstract] [Full Text] [Related]
4. Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers.
Akhtar A; Xiaoyan Wang S; Ghali L; Bell C; Wen X
J Biomed Res; 2017 Jan; 31(3):177-188. PubMed ID: 28808212
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles.
Piperoudi S; Fatouros D; Ioannou PV; Frederik P; Antimisiaris SG
Chem Phys Lipids; 2006 Feb; 139(2):96-106. PubMed ID: 16405880
[TBL] [Abstract][Full Text] [Related]
6. Arsonoliposome interaction with thiols: effect of pegylation and arsonolipid content of arsonoliposomes on their integrity during incubation in glutathione.
Haikou MN; Zagana P; Ioannou PV; Antimisiaris SG
J Nanosci Nanotechnol; 2006; 6(9-10):2974-8. PubMed ID: 17048506
[TBL] [Abstract][Full Text] [Related]
7. Arsonoliposomes: preparation and physicochemical characterization.
Antimisiaris SG; Ioannou PV
Methods Mol Biol; 2010; 605():147-62. PubMed ID: 20072879
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types.
Mourtas S; Papadia K; Kordopati GG; Ioannou PV; Antimisiaris SG; Tsivgoulis GM
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015274
[TBL] [Abstract][Full Text] [Related]
9. Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture.
Gortzi O; Antimisiaris SG; Klepetsanis P; Papadimitriou E; Ioannou PV
Eur J Pharm Sci; 2003 Feb; 18(2):175-83. PubMed ID: 12594011
[TBL] [Abstract][Full Text] [Related]
10. Arsonoliposomes: novel nanosized arsenic-containing vesicles for drug delivery.
Fatouros DG; Ioannou PV; Antimisiaris SG
J Nanosci Nanotechnol; 2006; 6(9-10):2618-37. PubMed ID: 17048471
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanofibers as novel carriers for the delivery of therapeutic molecules.
Kumbar SG; Nair LS; Bhattacharyya S; Laurencin CT
J Nanosci Nanotechnol; 2006; 6(9-10):2591-607. PubMed ID: 17048469
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnologies in protein delivery.
Salmaso S; Bersani S; Semenzato A; Caliceti P
J Nanosci Nanotechnol; 2006; 6(9-10):2736-53. PubMed ID: 17048478
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
